43 results
Page 2 of 3
8-K
EX-10.3
5iw4ae3
21 Jan 22
Entry into a Material Definitive Agreement
4:30pm
424B3
7l2q1pxoa ypi2mjt8do
14 Jan 22
Prospectus supplement
5:18pm
424B5
6ct8pa
23 Dec 21
Prospectus supplement for primary offering
5:01pm
424B5
lzwmk3wtc
1 Dec 21
Prospectus supplement for primary offering
5:10pm
DEF 14A
39oaad wp
22 Nov 21
Definitive proxy
4:37pm
424B5
o48osk2d
15 Oct 21
Prospectus supplement for primary offering
5:01pm
10-Q
mq3u6u uqd71n
14 May 21
Quarterly report
4:31pm
10-K
EX-10.1
6ku h0d3bhpoyxb
31 Mar 21
Annual report
4:30pm
10-K
vx06op
31 Mar 21
Annual report
4:30pm
S-3
wh5n8
29 Jan 21
Shelf registration
4:48pm
8-K/A
EX-99.1
oo7wfbb9q8154g
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K
EX-3.2
e6zb6vnewcn7d7mw 5y7
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
8-K
EX-10.1
3dcbujgkbsyurc7wytm
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
424B3
fgk6oxlyxri6jme7 fs
2 Nov 20
Prospectus supplement
12:00am